Aveo Capital Partners LLC Cuts Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Aveo Capital Partners LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 17.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,712 shares of the healthcare conglomerate’s stock after selling 356 shares during the period. Aveo Capital Partners LLC’s holdings in UnitedHealth Group were worth $866,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in UNH. International Assets Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Accredited Investors Inc. lifted its holdings in shares of UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after acquiring an additional 776,516 shares during the last quarter. Raymond James & Associates lifted its holdings in shares of UnitedHealth Group by 33.1% in the 3rd quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after acquiring an additional 587,088 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its holdings in shares of UnitedHealth Group by 129.7% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after acquiring an additional 581,324 shares during the last quarter. Finally, State Street Corp lifted its holdings in UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock valued at $26,626,387,000 after buying an additional 563,554 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $523.48 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a fifty day moving average price of $523.63 and a 200 day moving average price of $563.48. The stock has a market cap of $481.75 billion, a P/E ratio of 33.77, a P/E/G ratio of 1.45 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.